Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/29155
Title: Alemtuzumab improves clinical and MRI outcomes, including slowing of brain volume loss, in RRMS patients over 8 years: CARE-MS I follow-up (TOPAZ Study)
Authors: Comi, G.
Arnold, D. L.
Boyko, A. N.
Hartung, H. -P.
Havrdova, E. K.
Inshasi, J. S.
McCombe, P.
Nakamura, K.
Oreja-Guevara, C.
Pelletier, D.
Pozzilli, C.
Selmaj, K. W.
Scott, T. F.
Chung, L.
Daizadeh, N.
Afsar, S.
VAN WIJMEERSCH, Bart 
Issue Date: 2019
Publisher: WILEY
Source: EUROPEAN JOURNAL OF NEUROLOGY, 26(SI), p. 30-30
Notes: [Comi, G.] Univ Vita Salute San Raffaele, Milan, Italy. [Arnold, D. L.] NeuroRx Res, Montreal, PQ, Canada. [Boyko, A. N.] Pirogov Russian Natl Res Univ, Moscow, Russia. [Boyko, A. N.] Usupov Hosp, Demyelinating Dis Ctr, Moscow, Russia. [Hartung, H. -P.] Heinrich Heine Univ, Dusseldorf, Germany. [Havrdova, E. K.] Charles Univ Prague, Med Fac 1, Prague, Czech Republic. [Inshasi, J. S.] Rashid Hosp, Dubai, U Arab Emirates. [Inshasi, J. S.] Dubai Med Coll, Dubai, U Arab Emirates. [McCombe, P.] Univ Queensland, Brisbane, Qld, Australia. [Nakamura, K.] Cleveland Clin, Cleveland, OH 44106 USA. [Oreja-Guevara, C.] Univ Hosp San Carlos, Madrid, Spain. [Pelletier, D.] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA. [Pozzilli, C.] Univ Rome, Rome, Italy. [Selmaj, K. W.] Univ Warmia & Mazury, Olsztyn, Poland. [Scott, T. F.] Allegheny Gen Hosp, Pittsburgh, PA 15212 USA. [Chung, L.; Daizadeh, N.; Afsar, S.] Sanofi, Cambridge, MA USA. [Van Wijmeersch, B.] Hasselt Univ, BIOMED, Rehabil & MS Ctr Overpelt, Hasselt, Belgium.
Document URI: http://hdl.handle.net/1942/29155
ISSN: 1351-5101
e-ISSN: 1468-1331
ISI #: 000474481000048
Category: M
Type: Journal Contribution
Appears in Collections:Research publications

Show full item record

Page view(s)

42
checked on Jul 28, 2023

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.